Mr Lance Little

Head of Region Asia Pacific,
Roche Diagnostics

Trends and challenges in Molecular Tumour Board implementation in the Asia-Pacific Region: APAC MTB expert consensus statement

Dr Herbert Loong

Deputy Medical Director, Phase 1
Clinical Trial Centre,
The Chinese University of
Hong Kong

Moderated by: Dr Daniel Chan

ICON Cancer Centre Singapore

Unlocking the power of liquid biopsy-based profiling in clinical practice

Dr Linda Mileshkin

Peter MacCallum Cancer Centre

Moderated by: Dr Daniel Chan

Facilitating access to molecularly guided treatment options by leveraging advancements in genomic profiling and Molecular Tumour Boards

All

Moderated by: Dr Daniel Chan

Clinical utility and benefits of comprehensive genomic profiling: Evolving roles of CGP in ovarian and breast cancer

Dr Sewanti Limaye

Reliance Foundation Hospital &
Research Center, India

Moderated by: Dr Yoon Sim Yap
National Cancer Centre Singapore

Targeting PIK3CA mutations in breast cancer: From testing to  therapeutic strategies

Dr Dejan Juric

Director, Termeer Center for Targeted Therapies
and Investigational Cancer Therapeutics Program, Massachusetts General Hospital Cancer Centre

Moderated by: Dr Yoon-Sim Yap

Management of novel genes in breast cancer

All

Moderated by: Dr Yoon-Sim Yap

Dr Ahmed Elhusseiny

Area Head of APAC, Roche
Pharmaceuticals